{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:22:30Z","timestamp":1756902150857,"version":"3.44.0"},"reference-count":13,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:p>In recent years, rates of syphilis in adults have been on the rise resulting in an increase in the number of neonates born with congenital syphilis. National organizations including the Centers for Disease Control and Prevention as well as The US Preventative Services Task Force recommend routine testing of pregnant persons to identify and provide maternal syphilis treatment prior to delivery. Significant variability exists between states for these screenings, resulting in some pregnant persons not being diagnosed prior to delivery. The Pediatric Pharmacy Association (PPA) believes that pharmacists, along with other health care providers can help by ensuring optimal syphilis testing and treatment pathways for pregnant individuals and newborns are included in their workplaces. PPA also supports pharmacists working to increase treatment compliance by providing medication education and counseling regarding optimal treatment of syphilis infections, as well as work with state and local governments to standardize treatment recommendations.<\/jats:p>","DOI":"10.5863\/1551-6776-29.4.429","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T21:21:12Z","timestamp":1723584072000},"page":"429-433","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Pediatric Pharmacists in the Prevention and Treatment of Congenital Syphilis"],"prefix":"10.5863","volume":"29","author":[{"given":"Taylor","family":"Barnes","sequence":"first","affiliation":[{"name":"Department of Pharmacy (TB), Orlando Health, Orlando, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Girotto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice (JG), University of Connecticut, Storrs, CT"},{"name":"Division of Infectious Diseases and Immunology (JG), Connecticut Children\u2019s, Hartford CT"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3883","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"2024081321210715300_i2331-348X-29-4-429-b01","unstructured":"Centers for Disease Control and Prevention\n          . Preliminary 2021 STD surveillance data. National overview. Accessed March 3, 2023. https:\/\/www.cdc.gov\/std\/statistics\/2021\/default.htm"},{"issue":"22","key":"2024081321210715300_i2331-348X-29-4-429-b02","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6922a1","article-title":"Missed opportunities for prevention of congenital syphilis - United States, 2018","volume":"69","author":"Kimball","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"46","key":"2024081321210715300_i2331-348X-29-4-429-b03","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.15585\/mmwr.mm7246e1","article-title":"Vital signs: missed opportunities for preventing congenital syphilis - United States, 2022","volume":"72","author":"McDonald","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2024081321210715300_i2331-348X-29-4-429-b04","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2471\/BLT.12.107623","article-title":"Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis","volume":"91","author":"Gomez","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"3","key":"2024081321210715300_i2331-348X-29-4-429-b05","doi-asserted-by":"crossref","first-page":"e2020049080","DOI":"10.1542\/peds.2020-049080","article-title":"Congenital syphilis diagnosed beyond the neonatal period in the United States: 2014\u20132018","volume":"148","author":"Kimball","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"2024081321210715300_i2331-348X-29-4-429-b06","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/OLQ.0b013e31827c5b9f","article-title":"Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"4","key":"2024081321210715300_i2331-348X-29-4-429-b07","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"2024081321210715300_i2331-348X-29-4-429-b08","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jama.2018.11785","article-title":"Screening for syphilis infection in pregnant women: US Preventive Services Task Force reaffirmation recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"2024081321210715300_i2331-348X-29-4-429-b09","unstructured":"Centers for Disease Control and Prevention\n          . Sexually transmitted disease surveillance 2020. Centers for Disease Control and Prevention sexually transmitted disease surveillance web site. Accessed March 31, 2023. Updated 2020. https:\/\/www.cdc.gov\/std\/statistics\/2020\/tables\/20.htm"},{"key":"2024081321210715300_i2331-348X-29-4-429-b10","unstructured":"Centers for Disease Control and Prevention\n          . Sexually transmitted diseases (STDs), state statutory and regulatory language regarding prenatal syphilis screenings in the United States. Accessed March 9, 2023. https:\/\/www.cdc.gov\/std\/treatment\/syphilis-screenings.htm"},{"key":"2024081321210715300_i2331-348X-29-4-429-b11","unstructured":"National Institutes of Health\n          . Doxycycline. LactMed. Drugs and lactation database. 2021. Accessed February 9, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500561\/"},{"key":"2024081321210715300_i2331-348X-29-4-429-b12","first-page":"729","volume-title":"Redbook: 2021\u20132024 Report of the Committee on Infectious Diseases","author":"Kimberlin","year":"2021"},{"key":"2024081321210715300_i2331-348X-29-4-429-b13","unstructured":"Bachmann\n              L\n            , MenaL; Centers for Disease Control and Prevention. Clinical reminders during Bicillin L-A shortage. Updated 2023. https:\/\/www.cdc.gov\/std\/dstdp\/dcl\/2023-july-20-Mena-BicillinLA.htm Accessed 20 March 2023."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/4\/429\/3419103\/i2331-348x-29-4-429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/4\/429\/3419103\/i2331-348x-29-4-429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:41:40Z","timestamp":1738780900000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/4\/article-p429.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.4.429","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"type":"electronic","value":"2331-348X"},{"type":"print","value":"1551-6776"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}